Extracellular hyperthermia for the treatment of advanced cutaneous melanoma
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Tipo de documento: | Dissertação |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10362/134706 |
Resumo: | Nowadays, nanoparticles (NPs) are a promising approach to improve the efficiency of cancer therapies. Magnetic fluid hyperthermia is an emerging alternative to drug-dependent treatments, based on the application of an alternating magnetic field (AMF) in superparamagnetic iron oxide nanoparticles (SPIONs), promoting cell death by local heat dissipation. However, studies have shown that when SPIONs are internalized by cancer cells their magnetic-responsive properties change, ultimately reducing their heating capacity. Here, we aim to improve magnetic hyperthermia treatment efficiency by blocking the SPIONs internalization with small-molecule inhibitors of endocytosis (SMI). To study endocytosis, the internalization of SPIONs was assessed in a cell line of advanced cutaneous melanoma (WM983b). A time-course analysis of SPIONs internalization was performed in single-cell suspension model, 2D and 3D in vitro cell models. Due to the SPIONs surface charge influence in the cellular uptake mechanisms, studies were performed with SPIONs stabilized with dimercaptosuccinic acid (DMSA) (anionic NP) and 3-aminopropyl)triethoxysilane (APTES) (cationic NP) surfactants. Results demonstrate a rapid interaction between SPIONs and the cell membrane, more pronounced for cationic SPIONs. By labelling the APTES coated SPIONs with Rhodamine B fluorophore (RhoB), the blocking of cellular uptake was assessed by fluorescence microscopy. The inhibition of SPIONs_RhoB internalization was achieved with methyl-β-cyclodextrin endocytic inhibitor allowing only 14% of cellular uptake, suggesting receptor-mediated endocytosis as the uptake mechanism. In vitro magnetic hyperthermia was performed and the inhibition of the SPIONs internalization improved the NPs heating efficiency (SAR value of 91 ± 16 W/g) compared to intracellular hyperthermia (SAR value of 63 ± 7 W/g). Further studies are needed to evaluate the effects on cell death by apoptosis. Here, we show that the inhibition of NPs uptake is an effective approach to improve magnetic hyperthermia therapy. Besides, knowing the endocytic mechanism brings the possibility to develop new combined therapies by controllable endocytosis. However, more studies are required to accurately determine the specific endocytic route taken. |
id |
RCAP_2ab83da5232ee28c0a230393c14c1b0b |
---|---|
oai_identifier_str |
oai:run.unl.pt:10362/134706 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Extracellular hyperthermia for the treatment of advanced cutaneous melanomaendocytosismagnetic hyperthermiamelanomananotechnologysmall-molecule inhibitorssuperparamagnetic iron oxide nanoparticlesDomínio/Área Científica::Engenharia e Tecnologia::NanotecnologiaNowadays, nanoparticles (NPs) are a promising approach to improve the efficiency of cancer therapies. Magnetic fluid hyperthermia is an emerging alternative to drug-dependent treatments, based on the application of an alternating magnetic field (AMF) in superparamagnetic iron oxide nanoparticles (SPIONs), promoting cell death by local heat dissipation. However, studies have shown that when SPIONs are internalized by cancer cells their magnetic-responsive properties change, ultimately reducing their heating capacity. Here, we aim to improve magnetic hyperthermia treatment efficiency by blocking the SPIONs internalization with small-molecule inhibitors of endocytosis (SMI). To study endocytosis, the internalization of SPIONs was assessed in a cell line of advanced cutaneous melanoma (WM983b). A time-course analysis of SPIONs internalization was performed in single-cell suspension model, 2D and 3D in vitro cell models. Due to the SPIONs surface charge influence in the cellular uptake mechanisms, studies were performed with SPIONs stabilized with dimercaptosuccinic acid (DMSA) (anionic NP) and 3-aminopropyl)triethoxysilane (APTES) (cationic NP) surfactants. Results demonstrate a rapid interaction between SPIONs and the cell membrane, more pronounced for cationic SPIONs. By labelling the APTES coated SPIONs with Rhodamine B fluorophore (RhoB), the blocking of cellular uptake was assessed by fluorescence microscopy. The inhibition of SPIONs_RhoB internalization was achieved with methyl-β-cyclodextrin endocytic inhibitor allowing only 14% of cellular uptake, suggesting receptor-mediated endocytosis as the uptake mechanism. In vitro magnetic hyperthermia was performed and the inhibition of the SPIONs internalization improved the NPs heating efficiency (SAR value of 91 ± 16 W/g) compared to intracellular hyperthermia (SAR value of 63 ± 7 W/g). Further studies are needed to evaluate the effects on cell death by apoptosis. Here, we show that the inhibition of NPs uptake is an effective approach to improve magnetic hyperthermia therapy. Besides, knowing the endocytic mechanism brings the possibility to develop new combined therapies by controllable endocytosis. However, more studies are required to accurately determine the specific endocytic route taken.Atualmente, as nanopartículas (NPs) é uma das abordagens para melhorar a eficiência das terapias contra o cancro. A hipertermia magnética é uma alternativa emergente a tratamentos dependentes de fármacos, baseando-se na aplicação de um campo magnético alternado em nanopartículas superparamagnéticas de óxido de ferro, causando morte celular localizada por dissipação de calor. No entanto, estas NPs são internalizadas por células cancerígenas, alterando as suas propriedades magnéticas, reduzindo a sua capacidade de dissipar calor. O objetivo deste projeto é melhorar a eficiência do tratamento por hipertermia magnética, bloqueando a internalização das NPs com inibidores de endocitose. A dinâmica de internalização das NPs superparamagéticas foi estudada ao longo do tempo, in vitro em diferentes modelos celulares de uma linhagem de células de melanoma, de origem cutânea num estado avançado (WM983b). Devido à influência da carga superficial das NPs na internalização, comparou-se o comportamento de NPs estabilizadas com ácido dimercaptosuccínico (DMSA), carregadas negativamente, e com (3-aminopropil) trietoxissilano (APTES), carregadas positivamente. Os resultados demonstram uma interação rápida entre as NPs e a membrana celular, mais pronunciada para NPs carregadas positivamente. As NPs revestidas com APTES foram marcadas com fluoróforo de rodamina de modo a avaliar o impedimento da internalização por microscopia de fluorescência. O inibidor com maior capacidade de inibição foi o metil-β-ciclodextrina permitindo apenas 14% de internalização. Realizaram-se ensaios de hipertermia magnética in vitro que comprovaram que a inibição da internalização das NPs melhorou a eficiência do seu aquecimento (91 ± 16 W / g) em comparação com a hipertermia intracelular (63 ± 7 W / g). Mais estudos são necessários para avaliar os efeitos da terapia na morte celular. Comprovou-se que a inibição da internalização celular das NPs é uma abordagem eficiente para melhorar a terapia de hipertermia magnética. Para além disso, obtendo informação acerca do mecanismo de internalização possibilita desenvolvimento de novas terapias combinadas. No entanto, mais estudos são necessários para determinar com precisão qual o mecanismo de internalização.Almeida, FilipeSoares, PaulaRUNSimões, Beatriz Traguedo2022-11-29T01:32:47Z2022-02-242022-02-24T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://hdl.handle.net/10362/134706enginfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T05:13:10Zoai:run.unl.pt:10362/134706Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:48:12.804457Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Extracellular hyperthermia for the treatment of advanced cutaneous melanoma |
title |
Extracellular hyperthermia for the treatment of advanced cutaneous melanoma |
spellingShingle |
Extracellular hyperthermia for the treatment of advanced cutaneous melanoma Simões, Beatriz Traguedo endocytosis magnetic hyperthermia melanoma nanotechnology small-molecule inhibitors superparamagnetic iron oxide nanoparticles Domínio/Área Científica::Engenharia e Tecnologia::Nanotecnologia |
title_short |
Extracellular hyperthermia for the treatment of advanced cutaneous melanoma |
title_full |
Extracellular hyperthermia for the treatment of advanced cutaneous melanoma |
title_fullStr |
Extracellular hyperthermia for the treatment of advanced cutaneous melanoma |
title_full_unstemmed |
Extracellular hyperthermia for the treatment of advanced cutaneous melanoma |
title_sort |
Extracellular hyperthermia for the treatment of advanced cutaneous melanoma |
author |
Simões, Beatriz Traguedo |
author_facet |
Simões, Beatriz Traguedo |
author_role |
author |
dc.contributor.none.fl_str_mv |
Almeida, Filipe Soares, Paula RUN |
dc.contributor.author.fl_str_mv |
Simões, Beatriz Traguedo |
dc.subject.por.fl_str_mv |
endocytosis magnetic hyperthermia melanoma nanotechnology small-molecule inhibitors superparamagnetic iron oxide nanoparticles Domínio/Área Científica::Engenharia e Tecnologia::Nanotecnologia |
topic |
endocytosis magnetic hyperthermia melanoma nanotechnology small-molecule inhibitors superparamagnetic iron oxide nanoparticles Domínio/Área Científica::Engenharia e Tecnologia::Nanotecnologia |
description |
Nowadays, nanoparticles (NPs) are a promising approach to improve the efficiency of cancer therapies. Magnetic fluid hyperthermia is an emerging alternative to drug-dependent treatments, based on the application of an alternating magnetic field (AMF) in superparamagnetic iron oxide nanoparticles (SPIONs), promoting cell death by local heat dissipation. However, studies have shown that when SPIONs are internalized by cancer cells their magnetic-responsive properties change, ultimately reducing their heating capacity. Here, we aim to improve magnetic hyperthermia treatment efficiency by blocking the SPIONs internalization with small-molecule inhibitors of endocytosis (SMI). To study endocytosis, the internalization of SPIONs was assessed in a cell line of advanced cutaneous melanoma (WM983b). A time-course analysis of SPIONs internalization was performed in single-cell suspension model, 2D and 3D in vitro cell models. Due to the SPIONs surface charge influence in the cellular uptake mechanisms, studies were performed with SPIONs stabilized with dimercaptosuccinic acid (DMSA) (anionic NP) and 3-aminopropyl)triethoxysilane (APTES) (cationic NP) surfactants. Results demonstrate a rapid interaction between SPIONs and the cell membrane, more pronounced for cationic SPIONs. By labelling the APTES coated SPIONs with Rhodamine B fluorophore (RhoB), the blocking of cellular uptake was assessed by fluorescence microscopy. The inhibition of SPIONs_RhoB internalization was achieved with methyl-β-cyclodextrin endocytic inhibitor allowing only 14% of cellular uptake, suggesting receptor-mediated endocytosis as the uptake mechanism. In vitro magnetic hyperthermia was performed and the inhibition of the SPIONs internalization improved the NPs heating efficiency (SAR value of 91 ± 16 W/g) compared to intracellular hyperthermia (SAR value of 63 ± 7 W/g). Further studies are needed to evaluate the effects on cell death by apoptosis. Here, we show that the inhibition of NPs uptake is an effective approach to improve magnetic hyperthermia therapy. Besides, knowing the endocytic mechanism brings the possibility to develop new combined therapies by controllable endocytosis. However, more studies are required to accurately determine the specific endocytic route taken. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-11-29T01:32:47Z 2022-02-24 2022-02-24T00:00:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/masterThesis |
format |
masterThesis |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10362/134706 |
url |
http://hdl.handle.net/10362/134706 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799138083345530880 |